2022 annual financial data
Sutro Biopharma 2022 Net margin
Direct answer
Net margin was -175.89%.
Operating income was -128.94M USD and net income was -119.2M USD.
Operating cash flow was 3.55M USD.
Get free Sutro Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 67.77M USD
- Operating income
- -128.94M USD
- Net income
- -119.2M USD
- Operating cash flow
- 3.55M USD